JMPWA
SYNH

JP Morgan Private Wealth Advisors’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

JP Morgan Private Wealth Advisors’s Portfolio SYNH Stock Details SYNH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-16,192
Closed -$577K – 1964
2023
Q1 		$577K Sell
16,192
-5,430
-25% -$197K ﹤0.01% 1417
2022
Q4 		$793K Sell
21,622
-5,423
-20% -$214K ﹤0.01% 1260
2022
Q3 		$1.27M Sell
27,045
-643
-2% -$41.5K ﹤0.01% 1027
2022
Q2 		$1.99M Buy
27,688
+430
+2% +$31.4K 0.01% 859
2022
Q1 		$2.21M Sell
27,258
-1,599
-6% -$135K ﹤0.01% 868
2021
Q4 		$2.96M Sell
28,857
-1,911
-6% -$184K 0.01% 776
2021
Q3 		$2.69M Buy
30,768
+1,104
+4% +$99.9K 0.01% 780
2021
Q2 		$2.65M Buy
29,664
+3,545
+14% +$300K 0.01% 771
2021
Q1 		$1.98M Sell
26,119
-2,681
-9% -$202K 0.01% 770
2020
Q4 		$1.96M Buy
28,800
+1,644
+6% +$102K 0.01% 733
2020
Q3 		$1.44M Buy
27,156
+3,761
+16% +$224K 0.01% 746
2020
Q2 		$1.36M Buy
23,395
+14,523
+164% +$781K 0.01% 700
2020
Q1 		$350K Buy
8,872
+5,475
+161% +$320K ﹤0.01% 1072
2019
Q4 		$202K Buy
+3,397
New +$183K ﹤0.01% 1398
2017
Q2 		– Sell
-13,815
Closed -$633K – 1370
2017
Q1 		$633K Sell
13,815
-2,447
-15% -$122K ﹤0.01% 776
2016
Q4 		$856K Buy
16,262
+1,707
+12% +$82.6K 0.01% 637
2016
Q3 		$649K Buy
14,555
+3,965
+37% +$172K 0.01% 702
2016
Q2 		$404K Sell
10,590
-240
-2% -$10.5K ﹤0.01% 857
2016
Q1 		$447K Buy
10,830
+1,470
+16% +$60.6K ﹤0.01% 782
2015
Q4 		$454K Buy
9,360
+1,140
+14% +$50.7K ﹤0.01% 727
2015
Q3 		$329K Sell
8,220
-214
-3% -$9.35K ﹤0.01% 766
2015
Q2 		$338K Buy
+8,434
New +$291K ﹤0.01% 805

Other funds holding SYNH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
EIM
Elliott Investment Management West Palm Beach, Florida $20.1B AUM 60.76% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

JP Morgan Private Wealth Advisors's SYNH Position: Q2 2023 in Review

JP Morgan Private Wealth Advisors sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q2 2023, closing a stake of 16,192 shares — an estimated $577K sold.

JP Morgan Private Wealth Advisors first reported a position in SYNH in Q2 2015 and held it in 22 quarters. The position peaked at $2.96M in Q4 2021. 317 funds tracked by Wall St. Rank hold SYNH as of Q2 2023.

  • JP Morgan Private Wealth Advisors reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q2 2023 after selling out during the quarter.
  • JP Morgan Private Wealth Advisors sold 16,192 Syneos Health, Inc. Class A Common Stock shares in Q2 2023, an estimated $577K.
  • JP Morgan Private Wealth Advisors first reported a position in Syneos Health, Inc. Class A Common Stock in Q2 2015 and held it in 22 quarters.
  • JP Morgan Private Wealth Advisors's Syneos Health, Inc. Class A Common Stock position peaked at $2.96M in Q4 2021.
  • 317 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q2 2023.

Based on JP Morgan Private Wealth Advisors's 13F filing for Q2 2023, filed 28 Jul 2023.